SEC 13F Intelligence

Managers / Q4 2023 · view latest →

683 Capital Management, LLC

CIK 0001404574 · 1700 BROADWAY, SUITE 4200, NEW YORK, NY, 10019 · (212) 554-2379

Reported Value
$1.2B
Q4 2023
Positions
259
Filings on Record
32
2019–present window
Filed
Feb 14, 2024
original filing

Summary

683 Capital Management, LLC reported $1.2B in U.S.-listed holdings across 259 positions for Q4 2023.

Its largest position, BWA, represents 4.0% of the portfolio.

Compared with Q3 2023, the fund opened 134 new positions and exited 27.

Portfolio Metrics

Turnover
+20.2%
vs prior filed quarter
Top-10 Concentration
+29.9%
share of reported value
Largest Position
+4.0%
Borgwarner
New / Exited
134 / 27
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.7BQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.1BQ3 ’19: $899MQ4 ’19: $874MQ4 ’19Q1 ’20: $853MQ2 ’20: $1.2BQ3 ’20: $1.4BQ4 ’20: $2.1BQ4 ’20Q1 ’21: $1.9BQ2 ’21: $2.9BQ3 ’21: $2.6BQ4 ’21: $2.7BQ4 ’21Q1 ’22: $1.9BQ2 ’22: $1.4BQ3 ’22: $1.3BQ4 ’22: $1.2BQ4 ’22Q1 ’23: $1.3BQ2 ’23: $1.4BQ3 ’23: $1.3BQ4 ’23: $1.2BQ4 ’23Q1 ’24: $1.4BQ2 ’24: $1.3BQ3 ’24: $1.3BQ4 ’24: $1.6BQ4 ’24Q1 ’25: $1.4BQ2 ’25: $1.5BQ3 ’25: $1.9BQ4 ’25: $2.3BQ4 ’25Q1 ’26: $1.9Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 73.8%Other: 14.1%ADR: 4.3%US DOMESTIC: 3.1%Equity WRT: 2.7%Other: 1.9%
  • Common Stock · 73.8% · $901M
  • Other · 14.1% · $172M
  • ADR · 4.3% · $52M
  • US DOMESTIC · 3.1% · $38M
  • Equity WRT · 2.7% · $34M
  • Other · 1.9% · $24M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
IRSIRSA INVERSIONES Y REP S ANEW+2.23M2.23M+$19M$19M
NATLNCR ATLEOS CORPORATIONNEW+410.0K410.0K+$10M$10M
AAPLAPPLE INCNEW+25.0K25.0K+$5M$5M
AM6AMICUS THERAPEUTICS INCNEW+295.5K295.5K+$4M$4M
KLGWK KELLOGG CONEW+310.0K310.0K+$4M$4M
ZVRAZEVRA THERAPEUTICS INCNEW+540.8K540.8K+$4M$4M
ROIVANT SCIENCES LTDNEW+261.0K261.0K+$3M$3M
AUPHAURINIA PHARMACEUTICALS INCNEW+220.0K220.0K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

41 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1BWABORGWARNER INChistory →COM4.00%$49M1.36M
2COFCAPITAL ONE FINL CORPhistory →COM3.81%$47M355.0K
3EROERO COPPER CORPhistory →COM3.63%$44M2.80M
4HGVHILTON GRAND VACATIONS INChistory →COM3.48%$42M1.06M
5SHARKNINJA INCCOM SHS2.79%$34M665.0K
6OCCIDENTAL PETE CORP*W EXP 08/03/2022.72%$33M854.6K
7ENVAENOVA INTL INChistory →COM2.63%$32M580.0K
8TGTXTG THERAPEUTICS INChistory →COM2.34%$29M1.68M
9WAVE LIFE SCIENCES LTDSHS2.32%$28M5.60M
10GEHCGE HEALTHCARE TECHNOLOGIES Ihistory →COMMON STOCK2.15%$26M340.0K
11CDLXEURCARDLYTICS INChistory →COM · NOTE 1.000% 9/12.13%$26M20.56M
12XHRXENIA HOTELS & RESORTS INChistory →COM1.84%$22M1.65M
13RRYDER SYS INChistory →COM1.84%$22M195.0K
14GOOGLALPHABET INChistory →CAP STK CL A1.72%$21M150.0K
15LEN/BLENNAR CORPhistory →CL B1.70%$21M155.0K
16CVNACARVANA COhistory →CL A1.67%$20M385.0K
17WEAWESTERN ALLIANCE BANCORPhistory →COM1.62%$20M300.0K
18IRSIRSA INVERSIONES Y REP S Ahistory →SPON GDS ECH 101.57%$19M2.23M
19INSEINSPIRED ENTMT INChistory →COM1.48%$18M1.82M
20BRIDGEBIO PHARMA INCNOTE 2.500% 3/11.46%$18M14.75M
21MEIRAGTX HLDGS PLCCOM1.44%$18M2.50M
22PTGXPROTAGONIST THERAPEUTICS INChistory →COM1.34%$16M715.0K
23VYXNCR VOYIX CORPORATIONhistory →COM1.28%$16M925.0K
24TRVCCITIGROUP INChistory →COM NEW1.26%$15M300.0K
25CZRCAESARS ENTERTAINMENT INC NEhistory →COM1.19%$15M310.0K
26VSTVISTRA CORPhistory →COM1.18%$14M375.0K
27MREOMEREO BIOPHARMA GROUP PLChistory →SPON ADS1.17%$14M6.20M
28IOVAIOVANCE BIOTHERAPEUTICS INChistory →COM1.17%$14M1.75M
29IVVDINVIVYD INChistory →COM1.16%$14M3.60M
30GTXGARRETT MOTION INChistory →COM1.16%$14M1.46M
31RXORXO INChistory →COMMON STOCK1.12%$14M590.0K
32NOBLE CORP PLCORD SHS A0.99%$12M250.0K
33VALARIS LTDCL A0.98%$12M175.0K
34PHATPHATHOM PHARMACEUTICALS INChistory →COM0.96%$12M1.28M
35IMMATICS N.VSHS0.95%$12M1.10M
36VKTXVIKING THERAPEUTICS INChistory →COM0.95%$12M620.0K
37UNIQURE NVSHS0.94%$11M1.69M
38HRMYHARMONY BIOSCIENCES HLDGS INhistory →COM0.86%$10M325.0K
39NATLNCR ATLEOS CORPORATIONCOM SHS0.82%$10M410.0K
40SRPTSAREPTA THERAPEUTICS INCCOM0.68%$8M86.6K
41CD8CRESUD S A C I F Y ASPONSORED ADR0.67%$8M865.9K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$1.9B237May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$2.3B234Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$1.9B139Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$1.5B134Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.4B140May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$1.6B225Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$1.3B143Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$1.3B145Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$1.4B135May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.2B259Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.3B157Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.4B167Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.3B298May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.2B308Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B245Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B271Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.9B358May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$2.7B350Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$2.6B219Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.9B199Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.9B167May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$2.1B209Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.4B144Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.2B145Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$853M149May 15, 2020RESTATEMENTchanges · EDGAR ↗
Q4 2019$874M168Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$899M151Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.1B173Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.1B169May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.7B190Feb 15, 2019RESTATEMENTchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • 683 Capital Partners, LP028-14774

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.